Farmacosmo S.p.A. (BIT:COSMO)
Italy · Delayed Price · Currency is EUR 0.5180
0.00 (0.00%)
Last updated: Aug 12, 2025
Accolade Revenue
In the year 2024, Farmacosmo had annual revenue of 64.10M EUR, down -11.51%. Farmacosmo had revenue of 31.02M in the half year ending December 31, 2024, a decrease of -10.00%.
Revenue
64.10M
Revenue Growth
-11.51%
P/S Ratio
0.31
Revenue / Employee
674.76K
Employees
95
Market Cap
20.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64.10M | -8.34M | -11.51% |
| Dec 31, 2023 | 72.44M | 5.85M | 8.79% |
| Dec 31, 2022 | 66.59M | 8.09M | 13.83% |
| Dec 31, 2021 | 58.50M | 14.02M | 31.51% |
| Dec 31, 2020 | 44.48M | 20.17M | 82.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.48B |
| DiaSorin | 1.22B |
| Amplifon | 2.41B |
| EL.En. | 577.19M |
| Philogen | 77.65M |
| Safilo Group | 998.89M |
| GPI S.p.A. | 509.93M |
| Pharmanutra | 116.15M |